» Articles » PMID: 18305460

Persistent Alterations in Cognitive Function and Prefrontal Dopamine D2 Receptors Following Extended, but Not Limited, Access to Self-administered Cocaine

Overview
Date 2008 Feb 29
PMID 18305460
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Drug addicts have deficits in frontocortical function and cognition even long after the discontinuation of drug use. It is not clear, however, whether the cognitive deficits are a consequence of drug use, or are present prior to drug use, and thus are a potential predisposing factor for addiction. To determine if self-administration of cocaine is capable of producing long-lasting alterations in cognition, rats were allowed access to cocaine for either 1 h/day (short access, ShA) or 6 h/day (long access, LgA) for 3 weeks. Between 1 and 30 days after the last self-administration session, we examined performance on a cognitively demanding test of sustained attention that requires an intact medial prefrontal cortex. The expression levels of dopamine D1 and D2 receptor mRNA and D2 protein in the prefrontal cortex were also examined. Early after discontinuation of drug use, LgA (but not ShA) animals were markedly impaired on the sustained attention task. Although the LgA animals improved over time, they continued to show a persistent pattern of performance deficits indicative of a disruption of cognitive flexibility up to 30 days after the discontinuation of drug use. This was accompanied by a significant decrease in DA D2 (but not D1) mRNA in the medial and orbital prefrontal cortex, and D2 receptor protein in the medial prefrontal cortex of LgA (but not ShA) animals. These findings establish that repeated cocaine use is capable of producing persistent alterations in the prefrontal cortex and in cognitive function, and illustrate the usefulness of extended access self-administration procedures for studying the neurobiology of addiction.

Citing Articles

Bidirectional relationship between attentional deficits and escalation of nicotine intake in male rats.

Vouillac-Mendoza C, Ahmed S, Guillem K Psychopharmacology (Berl). 2024; 241(9):1895-1903.

PMID: 38743111 DOI: 10.1007/s00213-024-06604-x.


Modulation of Neuron and Astrocyte Dopamine Receptors via Receptor-Receptor Interactions.

Guidolin D, Tortorella C, Marcoli M, Cervetto C, De Caro R, Maura G Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895898 PMC: 10610355. DOI: 10.3390/ph16101427.


Voltage-gated potassium channels control extended access cocaine seeking: a role for nucleus accumbens astrocytes.

Xia M, Anderson T, Prantzalos E, Hawkinson T, Clarke H, Keohane S Neuropsychopharmacology. 2023; 49(3):551-560.

PMID: 37660129 PMC: 10789875. DOI: 10.1038/s41386-023-01718-w.


Cognitive Alterations in Addictive Disorders: A Translational Approach.

Gasparyan A, Maldonado Sanchez D, Navarrete F, Sion A, Navarro D, Garcia-Gutierrez M Biomedicines. 2023; 11(7).

PMID: 37509436 PMC: 10376598. DOI: 10.3390/biomedicines11071796.


BDNF as a therapeutic candidate for cocaine use disorders.

McGinty J Addict Neurosci. 2023; 2.

PMID: 37206683 PMC: 10195100. DOI: 10.1016/j.addicn.2022.100006.


References
1.
Rosselli M, Ardila A . Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol. 1996; 18(1):122-35. DOI: 10.1080/01688639608408268. View

2.
Ferrario C, Gorny G, Crombag H, Li Y, Kolb B, Robinson T . Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry. 2005; 58(9):751-9. DOI: 10.1016/j.biopsych.2005.04.046. View

3.
Volkow N, Fowler J, Wolf A, Hitzemann R, Dewey S, Bendriem B . Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 1991; 148(5):621-6. DOI: 10.1176/ajp.148.5.621. View

4.
Ahmed S, Koob G . Transition from moderate to excessive drug intake: change in hedonic set point. Science. 1998; 282(5387):298-300. DOI: 10.1126/science.282.5387.298. View

5.
Kozak R, Martinez V, Young D, Brown H, Bruno J, Sarter M . Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats. Neuropsychopharmacology. 2007; 32(10):2074-86. DOI: 10.1038/sj.npp.1301352. View